Publikationen, an denen er mitarbeitet ISMAEL GALVE ROPERH (15)

2020

  1. Cannabinoid-induced motor dysfunction via autophagy inhibition

    Autophagy, Vol. 16, Núm. 12, pp. 2289-2291

  2. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination

    eLife, Vol. 9, pp. 1-24

2016

  1. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling

    Neuropharmacology, Vol. 108, pp. 345-352

  2. Sustained Gq-protein signaling disrupts striatal circuits via JNK

    Journal of Neuroscience, Vol. 36, Núm. 41, pp. 10611-10624

2015

  1. The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway

    Cell Death and Differentiation, Vol. 22, Núm. 10, pp. 1618-1629

2014

  1. A restricted population of CB1 cannabinoid receptors with neuroprotective activity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 22, pp. 8257-8262

2011

  1. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

    Brain, Vol. 134, Núm. 1, pp. 119-136

  2. Reply: Reliability of immunolabelling in the determination of Huntington's disease neuropathy

    Brain

2008

  1. Targeting cannabinoid receptors in brain tumors

    Cannabinoids and the Brain (Springer US), pp. 361-374

2007

  1. Cannabinoids and gliomas

    Molecular Neurobiology, Vol. 36, Núm. 1, pp. 60-67

2006

  1. A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

    British Journal of Cancer, Vol. 95, Núm. 2, pp. 197-203

2005

  1. Cannabinoids and ceramide: Two lipids acting hand-by-hand

    Life Sciences

2004

  1. Hypothesis: Cannabinoid therapy for the treatment of gliomas?

    Neuropharmacology, Vol. 47, Núm. 3, pp. 315-323

2000

  1. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase

    FASEB Journal, Vol. 14, Núm. 14, pp. 2315-2322

1999

  1. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme

    Journal of Neurochemistry, Vol. 72, Núm. 4, pp. 1759-1768